Advertisement
Screener

CRESCENT BIOPHARMA, INC. (CBIO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

CRESCENT BIOPHARMA, INC. Cash Flow Breakdown

Cash flow breakdown shows where CRESCENT BIOPHARMA, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $71.53M went out.
  • Fiscal year ended 2025-12-31: from investing, $72.92M went out.
  • Fiscal year ended 2025-12-31: from financing, $322.98M came in.
  • Fiscal year ended 2025-12-31: change in cash, $178.53M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$71.53M-$72.92M$0.00$322.98M*$178.53M
2024-12-31-$31.10M$20.03K-$31.07M
2023-12-31-$34.88M-$21.39K$28.71M-$6.08M
2022-12-31-$46.46M-$84.19K$4.16M-$42.38M
2021-12-31-$57.49M-$14.94K$10.70M-$46.78M
2020-12-31-$39.24M-$68.51K$17.82M-$21.17M
2019-12-31-$51.98M-$144.93K-$51.72M
2018-12-31-$43.33M-$125.62K$128.43M$1.02M*$85.99M
2017-12-31-$29.77M-$294.11K$113.57M$83.88M
2016-12-31-$29.73M-$704.20K$23.60M-$6.76M
2015-12-31-$8.24M-$268.59K-$8.40M
2014-12-31-$4.28M-$212.60K$57.25M$52.89M
2013-12-31-$15.54M-$82.09K$558.93K*-$15.06M
2012-12-31-$10.47M-$326.18K-$10.80M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$19.46M*$1.76M*$0.00*
2026-03-31-$8.94M-$8.15M$0.00-$6.95M*-$24.03M
2025-12-31-$26.74M*-$72.19M*$0.00*$178.86M*
2025-09-30-$17.54M*-$586.00K*$0.00*-$1.25M*
2025-06-30-$16.40M*-$140.00K*$0.00*$146.86M*
2025-03-31-$10.85M$0.00$5.00K-$1.49M*-$12.34M
2024-12-31-$6.27M$0.00$315.00K$40.72M*$34.77M
2024-09-30-$7.99M*$0.00*
2024-06-30-$8.89M*-$2.53K*
2024-03-31-$10.51M-$7.44K-$10.51M
2023-12-31-$7.61M*-$801.00*$0.00*
2023-09-30-$8.68M*-$7.87K*$0.00*
2023-06-30-$6.97M*-$10.53K*$0.00*
2023-03-31-$11.61M-$2.20K$28.71M$17.13M
2022-12-31-$7.91M*-$1.00*
2022-09-30-$8.62M*-$2.48K*
2022-06-30-$16.23M*-$41.19K*
2022-03-31-$13.70M-$40.52K-$13.74M
2021-12-31-$12.81M*-$2.45K*$1.14M*
2021-09-30-$16.95M*-$4.33K*$0.00*
2021-06-30-$13.61M*-$5.10K*$0.00*
2021-03-31-$14.13M-$3.06K$9.56M-$4.56M
2020-12-31-$9.69M*-$38.17K*$3.71M*
2020-09-30-$11.50M*-$15.81K*$4.55M*
2020-06-30-$14.55M*-$6.38K*$9.58M*
2020-03-31-$3.50M-$8.14K-$3.38M
2019-12-31-$12.79M*-$12.36K*
2019-09-30-$13.45M*-$18.27K*
2019-06-30-$11.39M*-$74.77K*
2019-03-31-$14.35M-$39.54K-$14.36M
2018-12-31-$9.98M*-$57.00K*$0.00*
2018-09-30-$10.08M*-$26.56K*$0.00*$504.77K*
2018-06-30-$13.06M*-$25.44K*-$208.92K*
2018-03-31-$10.21M-$16.62K$128.63M$118.71M
2017-12-31-$8.37M*-$34.25K*$19.30M*$11.05M*
2017-09-30-$6.23M*-$32.69K*-$136.29K*-$6.28M*
2017-06-30-$6.11M*-$164.20K*$90.74M*$84.56M*
2017-03-31-$9.06M-$62.97K$3.67M-$5.45M
2016-12-31-$5.95M*-$438.57K*$1.15M*-$5.24M*
2016-09-30-$7.47M*-$225.38K*-$135.78K*-$7.80M*
2016-06-30-$7.07M*-$22.98K*$21.35M*$14.26M*
2016-03-31-$9.23M-$17.27K$1.24M-$7.97M
2015-12-31-$6.96M*-$3.23K*-$6.96M*
2015-09-30$13.56M*-$58.39K*$13.53M*
2015-06-30-$6.14M*-$204.64K*$15.16K*-$6.33M*
2015-03-31-$8.71M-$2.34K$75.38K-$8.63M
2014-12-31-$6.15M*-$14.87K*$0.00*-$6.16M*
2014-09-30-$4.75M*-$102.00K*$0.00*-$4.86M*
2014-06-30$9.21M*-$81.82K*-$8.17K*$9.25M*
2014-03-31-$2.59M-$13.92K$57.26M$54.66M
2013-12-31-$5.57M*-$12.43K*-$5.38M*
2013-09-30-$3.39M*-$39.17K*$0.00*-$3.09M*
2013-06-30-$2.71M*
2013-03-31-$3.88M-$6.82K-$3.88M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
Evolus, Inc. (EOLS)United States$0.519B-13.32
ARVINAS, INC. (ARVN)United States$0.510B58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82